Close X
Attorney Spotlight

What television show influenced Chad Jarboe's decision to pursue a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Primary Care Providers Win Challenge of CMS Interpretation of Enhanced Payment Law

With the help and support of the Tennessee Medical Association, 21 Tennessee physicians of underserved communities joined together and retained Bass, Berry & Sims to file suit against the Centers for Medicare & Medicaid Services to stop improper collection efforts. Our team, led by David King, was successful in halting efforts to recoup TennCare payments that were used legitimately to expand services in communities that needed them. Read more

Tennessee Medical Association & Bass, Berry & Sims

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Healthcare Transactions: Year in Review 2018Last year, CVS Health Corp. (NYSE: CVS) announced it would purchase health insurer Aetna Inc. (NYSE: AET) for $67.5 billion, a transaction that would be one of the biggest healthcare mergers in the past decade. The transaction raises an intriguing question: is this the beginning of a transformational shift in healthcare?

Recently, members of our healthcare group authored the Healthcare Transactions: Year in Review outlining 2017 M&A activity and drivers in the following hot healthcare sectors:

• Managed Care
• Hospitals
• Post-Acute Care—Home Health & Hospice
• Ambulatory Surgery Centers (ASCs)
• Healthcare Information Technology (HIT)
• Behavioral Health
• Physician Practice Management

Read now

Defense of Salix Pharmaceuticals in Multiple Jurisdictions

Client Type: Public Company

We represented Salix Pharmaceuticals in cases in multiple jurisdictions alleging renal failure suffered as a result of using a pharmaceutical product. The plaintiffs allegedly suffered renal failure after using a cleansing product that is routinely prescribed prior to a colonoscopy procedure. We conducted the initial investigation into the company's new drug application, amended warnings, adverse event reports, and other pertinent documents. We collected and preserved the pertinent documents through the use of a complimentary and secure extranet for the client. We identified and interviewed the key company executives and employees involved in the issues that were pertinent to the litigation. These cases focused on the adequacy of the warning labels that accompanied the product and alternative products that were less effective but arguably carried less risk to the patient. One case was dismissed after we deposed the plaintiff and obtained an admission during that deposition that she had just perjured herself after being confronted with a document that contradicted her testimony. Other cases were successfully resolved.

Salix Pharmaceuticals, Inc. (NASDAQ: SLXP) is a specialist pharmaceutical company that develops drugs and medical devices to prevent and treat various gastrointestinal disorders.

You Also May Be Interested In:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.